WordNet

the amount by which the cost of a business exceeds its revenue; "the company operated at a loss last year"; "the company operated in the red last year" (同)red ink, red
gradual decline in amount or activity; "weight loss"; "a serious loss of business"
something that is lost; "the car was a total loss"; "loss of livestock left the rancher bankrupt"
the disadvantage that results from losing something; "his loss of credibility led to his resignation"; "losing him is no great deprivation" (同)deprivation
the act of losing someone or something; "everyone expected him to win so his loss was a shock"
the experience of losing a loved one; "he sympathized on the loss of their grandfather"
remove the bones from; "bone the turkey before roasting it" (同)debone
the porous calcified substance from which bones are made (同)osseous_tissue
consisting of or made up of bone; "a bony substance"; "the bony framework of the body"
a shade of white the color of bleached bones (同)ivory, pearl, off-white
rigid connective tissue that makes up the skeleton of vertebrates (同)os
having bones as specified; "his lanky long-boned body"
having had the bones removed; "a boneless rib roast"; "a boned (or deboned) fish" (同)deboned
a percussion instrument consisting of a pair of hollow pieces of wood or bone (usually held between the thumb and fingers) that are made to click together (as by Spanish dancers) in rhythm with the dance (同)castanets, clappers, finger cymbals
subsequent to menopause

PrepTutorEJDIC

〈U〉(…を)『失うこと』,紛失《+『of』+『名』》 / 〈C〉(…の)『損害』,損失;損失額《+『of』+『名』》 / 〈U〉〈C〉(…に)『負けること』,(…の)敗北;失敗《+『of』+『名』》 / 〈U〉(状態・程度の)『減少』,低下 / 《複数形で》(戦場における)(人の)損害,此傷者数
〈C〉骨 / 〈U〉骨を作っている物質,骨質 / 《複数形で》骨格;死骸(がい) / 〈魚など〉‘の'骨を取る
(魚など)骨を取り除いた / (衣服が)(コルセットなどで)骨で張りをつけた[ような]

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 閉経後の女性における骨粗鬆症のマネージメントの概要 overview of the management of osteoporosis in postmenopausal women
2. 骨粗鬆症の予防および治療における閉経後のホルモン療法 postmenopausal hormone therapy in the prevention and treatment of osteoporosis
3. アロマターゼ阻害剤による骨量減少の評価およびマネージメント evaluation and management of aromatase inhibitor induced bone loss
4. 閉経前の骨粗鬆症の疫学および病因 epidemiology and etiology of premenopausal osteoporosis
5. 早期乳癌における骨吸収抑制剤の使用の概要 overview of the use of osteoclast inhibitors in early breast cancer

Renal impairment among postmenopausal women with osteoporosis from a large health plan in Israel.

Yu J1, Goldshtein I, Shalev V, Chodick G, Ish-Shalom S, Sharon O, Modi A.
Archives of osteoporosis.Arch Osteoporos.2015 Dec;10(1):210. doi: 10.1007/s11657-015-0210-y. Epub 2015 Mar 10.
Bisphosphonates are a first-line treatment for osteoporosis but require adequate renal function. We estimated the prevalence of renal impairment among osteoporotic women in Israeli. Approximately 2.3 % of women had renal impairment at a level that makes them inappropriate for bisphosphonate use, dem
PMID 25753617

Shiomi A1, Kawao N2, Yano M2, Okada K2, Tamura Y2, Okumoto K3, Matsuo O2, Akagi M4, Kaji H5.
Bone.Bone.2015 Oct;79:233-41. doi: 10.1016/j.bone.2015.06.009. Epub 2015 Jun 18.
The mechanism of postmenopausal osteoporosis is not fully understood. α2-Antiplasmin (α2-AP) is the primary inhibitor of plasmin in the fibrinolytic system, but is known to have activities beyond fibrinolysis. However, its role in bone metabolism and the pathogenesis of osteoporosis remains unknow
PMID 26094563

The effects of low-repetition and light-load power training on bone mineral density in postmenopausal women with sarcopenia: a pilot study

DHEA prevents bone loss by suppressing the expansion of CD4<sup>+</sup> T cells and TNFa production in the OVX-mouse model for postmenopausal osteoporosis